GLP-1 RA Litigation (e.g., Ozempic, Wegovy)
Accepting new clients
Glucagon-Like Peptide-1 Receptor Agonists (GLP-1 RA) medications like Ozempic and Wegovy are a class of medicine designed to treat Type 2 diabetes mellitus (T2DM) and obesity. However, beginning in August 2023, lawsuits have been filed against pharmaceutical companies Novo Nordisk and Eli Lilly for various injuries, including severe gastroparesis, intestinal blockages, vision loss, and death.
Sbaiti & Company is committed to holding pharmaceutical companies accountable for endangering public health. We have deep experience and a successful track record representing patients injured by dangerous drugs and medical devices.
What are GLP-1 RA’s?
GLP-1 receptor agonists are medications mainly used to help control blood sugar in people with Type 2 diabetes. GLP-1 stands for glucagon-like peptide-1, a hormone that helps manage blood sugar by increasing insulin production, slowing food digestion, and reducing appetite. GLP-1 RAs mimic these effects not only help lower blood sugar levels but can also lead to significant weight loss, which is why these drugs are now regularly used to treat obesity as well.
Some well-known GLP-1 medications include:
By Novo Nordisk:
- Ozempic (semaglutide)
- Rybelsus (semaglutide)
- Wegovy (semaglutide)
- Victoza (liraglutide)
- Saxenda (liraglutide)
By Eli Lilly:
- Trulicity (dulaglutide)
- Mounjaro (tirzepatide)
- Zepbound (tirzepatide)
- Byetta (exenatide)
Health Risks Associated with GLP-1 RA’s
GLP-1 RA drugs mimic hormones that reduce appetite and moderate insulin release, but the expected and unexpected risks of the drug can range in severity.
Adverse effects include:
- Abdominal Distension
- Abdominal Pain
- Acute Kidney Injury
- Birth Defects
- Constipation
- Diabetic Retinopathy
- Diarrhea
- Dizziness
- Dehydration
- Deep Vein Thrombosis (DVT)
- Dyspepsia (indigestion)
- Early Miscarriage
- Eructation (burping)
- Fatigue
- Gallbladder/ biliary disease
- Hair Loss
- Headache
- Hypersensitivity Reaction
- Hypoglycemia (low blood sugar)
- Ileus (bowel impaction)
- Malnutrition
- Nausea
- Pancreatitis
- Pulmonary Embolism (PE)
- Renal dysfunction/ failure
- Suicidal Ideation
- Tachycardia (elevated heart rate)
- Thrombocytopenia (low platelets)
- Thyroid Cancer
- Viral Gastroenteritis
- Vision Loss
- Vomiting
Other adverse effects may include
Stomach Paralysis (aka Gastroparesis) Symptoms:
- Abdominal bloating
- Abdominal pain
- Acid reflux
- Decreased quality of life
- Gastroparesis
- Lack of appetite
- Nausea
- Severe dehydration
- Vomiting
Gastroenteritis Symptoms
- Dehydration
- Diarrhea
- Fever
- Headaches
- Muscle aches
- Nausea
- Stomach cramps
- Vomiting
Ileus (Intestinal Blockages) Symptoms:
- Blood in stool
- Constipation
- Dark colored urine
- Diarrhea
- Difficulty with bowel movements
- Lack of appetite
- Lethargy
- Rapid heartbeat
- Swelling
- Vomiting
Muscle Loss (Sarcopenia) Symptoms:
- Decrease in muscle mass
- Difficulty performing daily activities
- Falls
- Loss of stamina
- Poor balance
- Trouble climbing stairs
- Walking slowly
GLP-1 RA Lawsuits
Personal injury lawsuits filed against Novo Nordisk and Eli Lilly claim manufacturers failed to adequately warn doctors and patients about the dangerous side effects of these drugs. Despite how heavily marketed these products are, many patients on these drugs are unaware of the severity of potential injuries and long-term risks.
Why Sbaiti & Company
Sbaiti & Company, a boutique law firm with offices in Texas and New Jersey, focuses on significant mass tort litigation and appeals. Our team comprises seasoned lawyers who have previously practiced at larger firms but now prefer the agility and personalized service that a boutique environment offers. Based in Dallas, our reach extends nationally and internationally, allowing us to serve clients effectively wherever they may be.
Clients choose Sbaiti & Company because of our track record of success and dedication to delivering tailored legal strategies. With experience representing plaintiffs across various areas, we offer a comprehensive understanding of complex litigation dynamics. Whether stepping in to resolve contentious matters, navigating trials, or handling post-trial appeals, our team is committed to achieving favorable outcomes for our clients. We prioritize clear communication, rapid responses to client concerns, and meticulous research and analysis, ensuring that our legal counsel is informed, strategic, and aligned with our clients’ objectives.
Related Cases
Sources
Practice Areas
Aqueous Film-Forming Foam (AFFF) Exposure and Contamination Litigation
Business Advisory and Outside General Counsel
Business & Commercial Disputes
Camp Lejeune Water Contamination Litigation
Catastrophic Injury & Wrongful Death
Construction Litigation
Creditor’s Right & Post-Judgment Collections
Director & Officer Defense
GLP-1 RA Litigation (e.g., Ozempic, Wegovy)
Human Trafficking Litigation
Investor & Securities Litigation
Patent & Intellectual Property Litigation
PCB Exposure and Contamination Litigation
PFAS “Forever Chemicals” Litigation
Roundup Exposure Litigation
Shareholder & Derivative Litigation
Suboxone Tooth Decay Litigation
Whistleblower & False Claims Act (FCA) Litigation
